151 related articles for article (PubMed ID: 21179890)
1. Basic and clinical proteomics from the EU Health Research perspective.
Dyląg T; Jehenson P; van de Loo JW; Sanne JL
Proteomics Clin Appl; 2010 Dec; 4(12):888-91. PubMed ID: 21179890
[TBL] [Abstract][Full Text] [Related]
2. Consensus document on European brain research.
Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
[TBL] [Abstract][Full Text] [Related]
3. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
4. How to Apply for and Secure EU Funding for Collaborative IBD Research Projects.
Satsangi J; Kitten O; Chavez M; Kalla R; Prel N; Meuwis MA; Scott S; Bonetti I; Ventham NT; Louis E
J Crohns Colitis; 2016 Mar; 10(3):363-70. PubMed ID: 26744440
[TBL] [Abstract][Full Text] [Related]
5. [Establishing ophthalmology in the research framework programs of the European Union].
Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
[TBL] [Abstract][Full Text] [Related]
6. Healthy bi-regional connection: The EU-LAC Health initiative has promoted equitable and collaborative health research and innovation.
Corral T; de Román M; Gómez-Núñez AJ; Mourenza B; Quental C; Splett-Rudolf S; de Andrés R
Health Res Policy Syst; 2018 Nov; 16(1):114. PubMed ID: 30470236
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery research in the European Union's Seventh Framework Programme for Research.
Frima HJ; Gabellieri C; Nilsson MI
J Control Release; 2012 Jul; 161(2):409-15. PubMed ID: 22333557
[TBL] [Abstract][Full Text] [Related]
8. A look inside the framework: EU funding priorities and criteria in the health theme of the co-operation programme.
Draghia-Akli R
Bioessays; 2010 Nov; 32(11):923-5. PubMed ID: 20824656
[No Abstract] [Full Text] [Related]
9. European Union vaccine research--an overview.
Sautter J; Olesen OF; Bray J; Draghia-Akli R
Vaccine; 2011 Sep; 29(39):6723-7. PubMed ID: 21195799
[TBL] [Abstract][Full Text] [Related]
10. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
11. [Research in biomedicine in collaboration with third country nationals within the 7th framework programme for years 2007-2013].
Kinkorová J
Cas Lek Cesk; 2012; 151(11):535-42. PubMed ID: 23301590
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer disease and associated disorders: project funding opportunities within the European community.
Sykes CM; Marks DF; McKinley JM
Alzheimer Dis Assoc Disord; 2001; 15(2):102-5. PubMed ID: 11403329
[TBL] [Abstract][Full Text] [Related]
13. European Union investment and countries' involvement in mental health research between 2007 and 2013.
Hazo JB; Gervaix J; Gandré C; Brunn M; Leboyer M; Chevreul K
Acta Psychiatr Scand; 2016 Aug; 134(2):138-49. PubMed ID: 27145870
[TBL] [Abstract][Full Text] [Related]
14. Transferring EU-funded biotechnology research to European bioindustry.
Lawler C; van der Meer R; Viseur J
Nat Biotechnol; 1998 Jun; 16(6):494. PubMed ID: 9624665
[No Abstract] [Full Text] [Related]
15. CORDIS - connecting scientists and stakeholders to the EU research funding opportunities.
N Biotechnol; 2008 Jun; 25(1):16-9. PubMed ID: 18504006
[No Abstract] [Full Text] [Related]
16. Enabling personalized medicine in Europe by the European Commission's funding activities.
Nimmesgern E; Norstedt I; Draghia-Akli R
Per Med; 2017 Jul; 14(4):355-365. PubMed ID: 29749834
[TBL] [Abstract][Full Text] [Related]
17. Proteomics data collection (ProDaC): publishing and collecting proteomics data sets in public repositories using standard formats.
Stephan C; Eisenacher M; Kohl M; Meyer HE
Methods Mol Biol; 2010; 604():345-68. PubMed ID: 20013383
[TBL] [Abstract][Full Text] [Related]
18. European research infrastructures for the development of nanobiotechnologies.
Péro H; Faure JE
Trends Biotechnol; 2007 May; 25(5):191-4. PubMed ID: 17368840
[TBL] [Abstract][Full Text] [Related]
19. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
Fears R; Kaufmann S; Ter Meulen V; Zumla A;
Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
[TBL] [Abstract][Full Text] [Related]
20. EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?
Schmidt L; Sehic O; Wild C
J Pharm Policy Pract; 2021 Apr; 14(1):37. PubMed ID: 33910624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
